Allergic Rhinitis.
Conditions
Interventions
Intervention 1: Control group: The placebo (normal saline) along with budesonide (64 micro gram), 2 puffs per nostril, three times a day for two weeks, is administered. Intervention 2: Intervention gr
Sponsors
Eadeh Darou Teb Company
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1)All patients with a positive SPT (Skin Prick Test) reaction to mix 10 tree, mix 7 grass, mix 5 weed, and mix Dermatophagoides 2) No medication use for at least one month prior to the study. 3)No history of asthma or contact dermatitis in patients who did not benefit from previous medical treatments.
Exclusion criteria
Exclusion criteria: If the patient was diagnosed with seasonal allergic rhinitis (AR) or if AR was not classified as moderate to severe (i.e., it was a mild form of the disease). Use of medication or immunotherapy in the past month. Pregnancy or age 65 years. AR associated with allergic conditions affecting other organs, such as asthma or skin allergies. Patients with a history of prior turbinate surgery, nasal septal abnormalities, nasal polyps or tumors, nasal radiotherapy, or recurrent sinusitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory allergens. Timepoint: Start of the study. Method of measurement: Skin prick test.;Severity of rhinorrhea. Timepoint: At the start of the study and two weeks after the intervention. Method of measurement: The Visual Analogue Scale.;Drug side effects. Timepoint: Two weeks after the intervention. Method of measurement: Questioner. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Farhad Seif
Iranian academic center for education culture and research
Outcome results
None listed